首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors
【24h】

Pharmacophore modelling and atom-based 3D-QSAR studies on N-methyl pyrimidones as HIV-1 integrase inhibitors

机译:N-甲基嘧啶酮作为HIV-1整合酶抑制剂的药效基团建模和基于原子的3D-QSAR研究

获取原文
       

摘要

Pharmacophore modelling and atom-based 3D-QSAR studies were carried out for a series of compounds belonging to N-methyl pyrimidones as HIV-1 integrase inhibitors. Based on the ligand-based pharmacophore model, we got 5-point pharmacophore model AADDR, with two hydrogen bond acceptors (A), two hydrogen bond donors (D) and one aromatic ring (R). The generated pharmacophore-based alignment was used to derive a predictive atom-based 3D-QSAR model for the training set (r2?=?0.92, SD?=?0.16, F?=?84.8, N?=?40) and for test set (Q2?=?0.71, RMSE?=?0.06, Pearson R?=?0.90, N?=?10). From these results, AADDR pharmacophore feature was selected as best common pharmacophore hypothesis, and atom-based 3D-QSAR results also support the outcome by means of favourable and unfavourable regions of hydrophobic and electron-withdrawing groups for the most potent compound 30. These results can be useful for further design of new and potent HIV-1 IN inhibitors.
机译:对一系列属于N-甲基嘧啶类化合物作为HIV-1整合酶抑制剂的化合物进行了药理学建模和基于原子的3D-QSAR研究。基于基于配体的药效团模型,我们得到了五点药效团模型AADDR,具有两个氢键受体(A),两个氢键供体(D)和一个芳环(R)。产生的基于药效基团的比对用于为训练集推导基于预测性原子的3D-QSAR模型(​​r 2 ?=?0.92,SD?=?0.16,F?=?84.8, N≤40,对于测试集(Q <sup> 2 ≤0.71,RMSE≤0.06,PearsonR≤0.90,N≤10)。从这些结果中,选择了ADDR药效基团特征作为最佳的通用药效基团假说,基于原子的3D-QSAR结果也通过最有效的化合物30的疏水基团和吸电子基团的有利和不利区域来支持这一结果。这些结果可用于进一步设计新型有效的HIV-1 IN抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号